RxDoctor Payments Data

Irina Shchedrov

Nurse Practitioner · Auburn, CANPI 1669067013

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 30 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 10.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,360, more than ten times the $115 reported in 2021. Among nurse practitioner clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,440in general payments, 2019–2025

Across 30 payments — averaging $114.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$376
  • Gilead$346
  • Johnson & Johnson$292
  • Daiichi Sankyo Inc.$275
  • AstraZeneca$241
  • Novo Nordisk$223
  • plus $2K from 15 others

What the payments were for

  • Food & beverage$3,440100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,440 in reported general payments places this provider in the 90th percentile of 6,779 nurse practitioner providers in California.

See all nurse practitioner providers in California →

Medicare billing

Part B allowed, 2024
$3,064
Medicare patients
29
Services billed
31

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl11$33

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Auburn

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →